Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care

NCT ID: NCT01517178

Last Updated: 2015-03-13

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE3

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary object of this study is to provide clinical documentation for the New base plate significantly 'reduces the degree of Leakage' under the base plate compared to Standard Care base plates.

The secondary objectives are to provide clinical documentation on several performance and safety parameters on the New base plate compared to Standard Care base plates.

The primary hypothesis is that the New base plate significantly reduces degree of leakage under the base plate compared to Standard Care base plates.

Each test period will last for two weeks. In addition to this there will be one week run-in period on New base plate. The data will be collected by investigator in the Case Report Form at the inclusion visit, cross-over visit and termination visit. Data will also be collected by the subject in a questionnaire during the two test periods.

The subjects will change their base plates on per need basis and continue with their normal changing pattern in the entire study period.

100 subjects with ileostomy will be included in the study. The subjects will be recruited from Europe including Denmark, Norway, Sweden, Iceland, Germany and France.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leakage Skin Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Care base plate

Standard care are the participants own product and can have several manufacture and brand names

Group Type ACTIVE_COMPARATOR

Standard Care base plate

Intervention Type DEVICE

The base plate is applied to the skin around the stoma and an ostomy bag is clicked onto the base plate.

New ostomy base plate (SS)

SS = New ostomy base plate. Due to company confidentiality the product is called SS and this is not short for any name

Group Type EXPERIMENTAL

New ostomy base plate (SS)

Intervention Type DEVICE

The base plate is applied to the skin around the stoma and an ostomy bag is clicked onto the base plate.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

New ostomy base plate (SS)

The base plate is applied to the skin around the stoma and an ostomy bag is clicked onto the base plate.

Intervention Type DEVICE

Standard Care base plate

The base plate is applied to the skin around the stoma and an ostomy bag is clicked onto the base plate.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Have given written Informed Consent
2. Is at least 18 years old
3. Has the mental capacity to understand the study guidelines and questionnaires
4. Has had their ileostomy for at least 3 months
5. Has an ileostomy with a diameter between 19-40 mm
6. Is currently using a flat 2-piece product with with mechanical coupling
7. Is able to change the base plate by themselves or with help from a caregiver (e.g. spouse)
8. Has experienced leakage under the base plate at least once a week over the last 2 weeks

Exclusion Criteria

1. Is pregnant or breast-feeding
2. Currently receiving or has within the past 2 months received radio- and/or chemotherapy
3. Currently using topical steroid product on peristomal skin (injections and oral treatment are accepted)
4. Is currently using a convex base plate
5. Participating in other clinical studies or has previously participated in this study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sygehus Sønderjylland i Aabenraa

Aabenraa, , Denmark

Site Status

Bispebjerg Hospital

Copenhagen, , Denmark

Site Status

Hvidovre Hospital

Hvidovre, , Denmark

Site Status

Odense Universitetshospital

Odense, , Denmark

Site Status

Hôpital Nord

Marseille, , France

Site Status

Hôpital Hôtel Dieu de Nantes

Nantes, , France

Site Status

Hôpital Lariboisière

Paris, , France

Site Status

CHRU La Milétrie

Poitiers, , France

Site Status

Hôpital de Pontchaillou, CHRU de Rennes

Rennes, , France

Site Status

Sanitätshaus Fürst GmbH

Passau, , Germany

Site Status

Landspitali University Hospital

Reykjavik, , Iceland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark France Germany Iceland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP215OC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP376 OCT Exploratory Skin Study
NCT06965140 COMPLETED NA